INTERCEPT PHARMACEUTICALS
Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, an FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases
INTERCEPT PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.interceptpharma.com
Total Employee:
501+
Status:
Active
Contact:
+1 646 747 1000
Total Funding:
567.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
2008-01-01
Board_member
2006-01-01
Board_member
Board_member
2008-01-01
Current Employees Featured
Christian Weyer Executive Vice President of Research & Development @ Intercept Pharmaceuticals
Executive Vice President of Research & Development
2017-11-01
Drew Cronin-Fine Executive Director, US Marketing @ Intercept Pharmaceuticals
Executive Director, US Marketing
2021-10-01
Sandip Kapadia CFO @ Intercept Pharmaceuticals
CFO
Mark Pruzanski Founder, Strategic Advisor and Board Member @ Intercept Pharmaceuticals
Founder, Strategic Advisor and Board Member
2021-01-01
Lixia Wang Vice President @ Intercept Pharmaceuticals
Vice President
2019-02-01
David Shapiro Chief Medical Officer @ Intercept Pharmaceuticals
Chief Medical Officer
Gail Cawkwell Senior Vice President Medical Affairs, Safety, and Pharmacovigalence and Section 16 Officer @ Intercept Pharmaceuticals
Senior Vice President Medical Affairs, Safety, and Pharmacovigalence and Section 16 Officer
2018-02-01
Daniel M. Bradbury Director @ Intercept Pharmaceuticals
Director
2016-07-01
Caroline Stockwell VP, Head of Legal International @ Intercept Pharmaceuticals
VP, Head of Legal International
2020-10-01
Roberto Pellicciari Co-Founder & Head of Medicinal Chemistry @ Intercept Pharmaceuticals
Co-Founder & Head of Medicinal Chemistry
Founder
Stock Details
Investors List
Aisling Capital
Aisling Capital investment in Series C - Intercept Pharmaceuticals
OrbiMed
OrbiMed investment in Series C - Intercept Pharmaceuticals
Genextra
Genextra investment in Series B - Intercept Pharmaceuticals
Genextra
Genextra investment in Series A - Intercept Pharmaceuticals
Jafco Life Science
Jafco Life Science investment in Venture Round - Intercept Pharmaceuticals
Genextra
Genextra investment in Venture Round - Intercept Pharmaceuticals
Balyasny Asset Management
Balyasny Asset Management investment in Venture Round - Intercept Pharmaceuticals
Rodman & Renshaw
Rodman & Renshaw investment in Debt Financing - Intercept Pharmaceuticals
Official Site Inspections
http://www.interceptpharma.com Semrush global rank: 3.44 M Semrush visits lastest month: 4.45 K
- Host name: server-108-156-120-64.ord56.r.cloudfront.net
- IP address: 108.156.120.64
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Intercept Pharmaceuticals"
Intercept Pharmaceuticals - Crunchbase Company …
Contact Email info@interceptpharma.com Phone Number +1 646 747 1000 Intercept Pharmaceuticals is a biopharmaceutical company, that engages in …See details»
Intercept Pharmaceuticals - LinkedIn
Intercept Pharmaceuticals | 66,287 followers on LinkedIn. Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases. | We are a biopharmaceutical company and ...See details»
About Us - Intercept Pharmaceuticals
YOU ARE NOW leaving interceptpharma.com. The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website. The site you will be entering is intended for U.S. audiences only. Continue. If you are a …See details»
Intercept Pharmaceuticals, Inc. (ICPT) Company Profile & Overview
Oct 11, 2012 It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New …See details»
Intercept Pharmaceuticals - Overview, News & Similar companies ...
Jun 17, 2024 Explore Complete Organization Structure. Is Intercept Pharmaceuticals your ideal customer? Let us give you the heads up on whether it's a good time to reach out ... (646) 747 …See details»
Intercept Pharmaceuticals Company Profile | Management and
SQL International Organization for Standardization . CSS World Wide Web Consortium . Web Analytics (5 Technologies) Google Global Site Tag Google . ... Smith@interceptpharma.com: …See details»
Intercept Pharmaceuticals Inc - Company Profile - GlobalData
Website www.interceptpharma.com Telephone 1 646 7471000. No of Employees 341. Industry Pharmaceuticals and Healthcare. Revenue (2022) $285.7M Gain access to our ...See details»
Intercept Pharmaceuticals - Company Profile & Staff Directory
Intercept Pharmaceuticals is a Pharmaceuticals company located in 305 Madison Ave, Morristown, New Jersey 07960, US with 495 employees. Access Intercept Pharmaceuticals's …See details»
Alfasigma completes acquisition of Intercept …
Nov 8, 2023 Bologna, Italy & Morristown, N.J., U.S. – November 8, 2023 – Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ( “Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma …See details»
Grant Application - Intercept Pharmaceuticals
Letter of Request on organization’s letterhead; Program agenda / brochure; Completed W-9 Form; Submit all completed documents to grants@interceptpharma.com;See details»
Intercept Pharmaceuticals - Employees, Contact info, Overview
May 1, 2024 View info about Intercept Pharmaceuticals (interceptpharma.com). Intercept Pharmaceuticals is a company located in Morristown, New Jersey, United States. Find …See details»
Working at Intercept Pharmaceuticals - Zippia
Www.interceptpharma.com. Organization Type. Public. CEO. Jerome B. Durso. Social Media. Intercept Pharmaceuticals focuses on developing solutions to treat progressive non-viral liver …See details»
Intercept Pharmaceuticals - Craft
Nov 14, 2023 Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as …See details»
Intercept Pharmaceuticals, Inc. Company Information - Drugs.com
Aug 31, 2015 Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided …See details»
Intercept Pharmaceuticals - Company Profile & Staff Directory
We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary …See details»
Top 20 Biotechnology Innovators in New Jersey - Inven
Accurant Biotech is an outsourcing organization (CRO) specializing in immune-based and cell-based method development, validation, and sample analysis for clinical and preclinical trials in …See details»
Gumax | Non-Profit Organization In Woodbridge
Gumax is a dedicated non-profit organization in Woodbridge, committed to uplifting our community through various impactful initiatives and programs. Skip to content. f; t; g; i; y; 609 …See details»
Medical Device Contract Manufacturing – Sterling Industries
We start by understanding your design ideas, and offer design engineering, as well as Design for Manufacturing & Assembly (DFMA) expertise.We source materials and negotiate with trusted …See details»
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial …
Mar 31, 2025 Organization: PUB. Release Versions. English Spanish (Summary) German French Italian (Summary) Dutch (Summary) Contacts. Investor inquiries: ir@corcept.com …See details»
‘You’re Never Too Busy For Your Banker’: How Italy’s ... - OCCRP
Apr 18, 2024 In order for investigators to zero in on the Figliomeni organization’s considerable wealth, Canadian police obtained judicial orders that compelled four of the country’s biggest …See details»